remissions

the patient experienced several spontaneous remissions during treatment.

achieving long-term remissions is the goal of many cancer therapies.

we are investigating factors that contribute to durable remissions in ms patients.

the study evaluated the rate of remissions following the new drug regimen.

maintaining remissions requires ongoing monitoring and potential adjustments to treatment.

the doctor discussed the possibility of complete remissions with the family.

relapse-free remissions are a positive indicator of treatment success.

the research focused on identifying biomarkers associated with sustained remissions.

early remissions often correlate with a more favorable prognosis.

the clinical trial aimed to improve the proportion of patients achieving remissions.

partial remissions were observed in a significant number of participants.